Free Trial

Cabot (CBT) to Release Quarterly Earnings on Tuesday

Cabot logo with Basic Materials background
Image from MarketBeat Media, LLC.

Cabot (NYSE:CBT - Get Free Report) will likely be announcing its Q2 2026 results after the market closes on Tuesday, May 5th. Analysts expect the company to announce earnings of $1.47 per share and revenue of $900.7710 million for the quarter. Cabot has set its FY 2026 guidance at 6.000-6.500 EPS. Investors may visit the the company's upcoming Q2 2026 earning results page for the latest details on the call scheduled for Wednesday, May 6, 2026 at 8:00 AM ET.

Cabot (NYSE:CBT - Get Free Report) last posted its quarterly earnings results on Tuesday, February 3rd. The specialty chemicals company reported $1.53 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.40 by $0.13. The business had revenue of $849.00 million during the quarter, compared to analyst estimates of $889.11 million. Cabot had a return on equity of 22.82% and a net margin of 8.62%.The business's revenue was down 11.1% compared to the same quarter last year. During the same period in the prior year, the business earned $1.76 earnings per share. On average, analysts expect Cabot to post $6 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Cabot Price Performance

CBT stock opened at $77.32 on Tuesday. The company has a debt-to-equity ratio of 0.49, a current ratio of 1.67 and a quick ratio of 1.09. The business has a 50 day simple moving average of $73.51 and a 200-day simple moving average of $70.02. The firm has a market capitalization of $4.04 billion, a PE ratio of 13.54, a price-to-earnings-growth ratio of 10.13 and a beta of 0.84. Cabot has a 1 year low of $58.33 and a 1 year high of $83.71.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the company. Global Retirement Partners LLC lifted its stake in Cabot by 1,606.9% during the fourth quarter. Global Retirement Partners LLC now owns 495 shares of the specialty chemicals company's stock worth $33,000 after purchasing an additional 466 shares in the last quarter. Danske Bank A S acquired a new position in Cabot during the third quarter worth $38,000. Geneos Wealth Management Inc. lifted its stake in Cabot by 409.0% during the first quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company's stock worth $38,000 after purchasing an additional 364 shares in the last quarter. Caitong International Asset Management Co. Ltd lifted its stake in Cabot by 709.1% during the third quarter. Caitong International Asset Management Co. Ltd now owns 534 shares of the specialty chemicals company's stock worth $41,000 after purchasing an additional 468 shares in the last quarter. Finally, Advisory Services Network LLC acquired a new position in Cabot during the third quarter worth $57,000. 93.18% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research analysts recently commented on CBT shares. Zacks Research upgraded Cabot from a "strong sell" rating to a "hold" rating in a report on Tuesday, January 27th. Jefferies Financial Group reiterated a "buy" rating and issued a $85.00 price objective on shares of Cabot in a report on Wednesday, February 4th. UBS Group upped their price objective on Cabot from $74.00 to $81.00 and gave the company a "neutral" rating in a report on Thursday, February 5th. Weiss Ratings reiterated a "hold (c-)" rating on shares of Cabot in a report on Monday, December 29th. Finally, Mizuho set a $75.00 price objective on Cabot and gave the company a "neutral" rating in a report on Wednesday, February 4th. One investment analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $73.75.

Get Our Latest Analysis on Cabot

Cabot Company Profile

(Get Free Report)

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

Featured Stories

Earnings History for Cabot (NYSE:CBT)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cabot Right Now?

Before you consider Cabot, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cabot wasn't on the list.

While Cabot currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines